363 related articles for article (PubMed ID: 29902700)
1. Ticagrelor, a P2Y12 antagonist, attenuates vascular dysfunction and inhibits atherogenesis in apolipoprotein-E-deficient mice.
Ganbaatar B; Fukuda D; Salim HM; Nishimoto S; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Soeki T; Sata M
Atherosclerosis; 2018 Aug; 275():124-132. PubMed ID: 29902700
[TBL] [Abstract][Full Text] [Related]
2. Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.
Chen X; Qian S; Hoggatt A; Tang H; Hacker TA; Obukhov AG; Herring PB; Seye CI
Arterioscler Thromb Vasc Biol; 2017 Jan; 37(1):75-83. PubMed ID: 27856454
[TBL] [Abstract][Full Text] [Related]
3. Protease-Activated Receptor-2 Plays a Critical Role in Vascular Inflammation and Atherosclerosis in Apolipoprotein E-Deficient Mice.
Hara T; Phuong PT; Fukuda D; Yamaguchi K; Murata C; Nishimoto S; Yagi S; Kusunose K; Yamada H; Soeki T; Wakatsuki T; Imoto I; Shimabukuro M; Sata M
Circulation; 2018 Oct; 138(16):1706-1719. PubMed ID: 29700120
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of S1P Receptor 2 Attenuates Endothelial Dysfunction and Inhibits Atherogenesis in Apolipoprotein E-Deficient Mice.
Ganbaatar B; Fukuda D; Shinohara M; Yagi S; Kusunose K; Yamada H; Soeki T; Hirata KI; Sata M
J Atheroscler Thromb; 2021 Jun; 28(6):630-642. PubMed ID: 32879149
[TBL] [Abstract][Full Text] [Related]
5. Chondroitin Sulphate Attenuates Atherosclerosis in ApoE Knockout Mice Involving Cellular Regulation of the Inflammatory Response.
Melgar-Lesmes P; Sánchez-Herrero A; Lozano-Juan F; de la Torre Hernández JM; Montell E; Jiménez W; Edelman ER; Balcells M
Thromb Haemost; 2018 Jul; 118(7):1329-1339. PubMed ID: 29874688
[TBL] [Abstract][Full Text] [Related]
6. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice.
Lu J; Xiang G; Liu M; Mei W; Xiang L; Dong J
Atherosclerosis; 2015 Dec; 243(2):438-48. PubMed ID: 26520898
[TBL] [Abstract][Full Text] [Related]
7. Vildagliptin, a DPP-4 Inhibitor, Attenuates Endothelial Dysfunction and Atherogenesis in Nondiabetic Apolipoprotein E-Deficient Mice.
Aini K; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Yagi S; Kusunose K; Yamada H; Soeki T; Sata M
Int Heart J; 2019 Nov; 60(6):1421-1429. PubMed ID: 31735774
[TBL] [Abstract][Full Text] [Related]
8. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
[TBL] [Abstract][Full Text] [Related]
9. P2Y
Niu X; Pi SL; Baral S; Xia YP; He QW; Li YN; Jin HJ; Li M; Wang MD; Mao L; Hu B
Arterioscler Thromb Vasc Biol; 2017 Mar; 37(3):515-524. PubMed ID: 28062501
[TBL] [Abstract][Full Text] [Related]
10. Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K; Shirai R; Hontani M; Shinooka R; Hasegawa A; Kichise T; Yamashita T; Yoshizawa H; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411243
[TBL] [Abstract][Full Text] [Related]
11. The anti-inflammatory vasostatin-2 attenuates atherosclerosis in ApoE
Xiong W; Wang X; Dai D; Zhang B; Lu L; Tao R
Thromb Haemost; 2017 Jan; 117(2):401-414. PubMed ID: 27831589
[TBL] [Abstract][Full Text] [Related]
12. Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice.
Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
Vascul Pharmacol; 2016 Apr; 79():16-23. PubMed ID: 26277250
[TBL] [Abstract][Full Text] [Related]
13. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice.
Zhang W; Tang T; Nie D; Wen S; Jia C; Zhu Z; Xia N; Nie S; Zhou S; Jiao J; Dong W; Lv B; Xu T; Sun B; Lu Y; Li Y; Cheng L; Liao Y; Cheng X
Cardiovasc Res; 2015 Jun; 106(3):453-64. PubMed ID: 25784693
[TBL] [Abstract][Full Text] [Related]
14. Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R; Sato K; Yamashita T; Yamaguchi M; Okano T; Watanabe-Kominato K; Watanabe R; Matsuyama TA; Ishibashi-Ueda H; Koba S; Kobayashi Y; Hirano T; Watanabe T
J Am Heart Assoc; 2018 Feb; 7(3):. PubMed ID: 29420219
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban, a novel oral anticoagulant, attenuates atherosclerotic plaque progression and destabilization in ApoE-deficient mice.
Hara T; Fukuda D; Tanaka K; Higashikuni Y; Hirata Y; Nishimoto S; Yagi S; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Sata M
Atherosclerosis; 2015 Oct; 242(2):639-46. PubMed ID: 25817329
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of endothelial NF-κB signaling attenuates chronic intermittent hypoxia-induced atherosclerosis in mice.
Song D; Fang G; Mao SZ; Ye X; Liu G; Miller EJ; Greenberg H; Liu SF
Atherosclerosis; 2018 Mar; 270():68-75. PubMed ID: 29407890
[TBL] [Abstract][Full Text] [Related]
17. Dapagliflozin attenuates human vascular endothelial cell activation and induces vasorelaxation: A potential mechanism for inhibition of atherogenesis.
Gaspari T; Spizzo I; Liu H; Hu Y; Simpson RW; Widdop RE; Dear AE
Diab Vasc Dis Res; 2018 Jan; 15(1):64-73. PubMed ID: 28976221
[TBL] [Abstract][Full Text] [Related]
18. Vascular Semaphorin 7A Upregulation by Disturbed Flow Promotes Atherosclerosis Through Endothelial β1 Integrin.
Hu S; Liu Y; You T; Heath J; Xu L; Zheng X; Wang A; Wang Y; Li F; Yang F; Cao Y; Zhang H; van Gils JM; van Zonneveld AJ; Jo H; Wu Q; Zhang Y; Tang C; Zhu L
Arterioscler Thromb Vasc Biol; 2018 Feb; 38(2):335-343. PubMed ID: 29269512
[TBL] [Abstract][Full Text] [Related]
19. Bmper inhibits endothelial expression of inflammatory adhesion molecules and protects against atherosclerosis.
Pi X; Lockyer P; Dyer LA; Schisler JC; Russell B; Carey S; Sweet DT; Chen Z; Tzima E; Willis MS; Homeister JW; Moser M; Patterson C
Arterioscler Thromb Vasc Biol; 2012 Sep; 32(9):2214-22. PubMed ID: 22772758
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor, but not clopidogrel, reduces arterial thrombosis via endothelial tissue factor suppression.
Reiner MF; Akhmedov A; Stivala S; Keller S; Gaul DS; Bonetti NR; Savarese G; Glanzmann M; Zhu C; Ruf W; Yang Z; Matter CM; Lüscher TF; Camici GG; Beer JH
Cardiovasc Res; 2017 Jan; 113(1):61-69. PubMed ID: 28028070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
